Track
:
Track 04: Nonclinical and Translational Development/Early Phase Clinical Development
Program Code:
106
Date:
Monday, June 24, 2013
Time:
11:00 AM to 12:30 PM
EST
Location:
105
CHAIR
:
Barry Mangum, MD (SCHNON), Director, Clinical Pharmacology, Duke University Medical Center, United States
He has an extensive background in neonatal and pediatric pharmacology and is the co-author and co-publisher of the leading drug dosing manual, NeoFax. He has represented the interest of pediatric patients by chairing and speaking at on the topic of neonatal pharmacology and legislative issues.
SPEAKER
(S):
Jack Xu, MD,MBA,MS (SPKSUP), Senior Vice President, Shanghai Clinical Research Center (SCRC), China
Dr. Juncai Xu Vice Director of SCRC. He received master’s degree from Shanghai Medical University, 1994 as a CRA, Medical Manager Upjohn(1995-1997); Regulatory Manager, Ranbaxy (1997-2000); Medical Director of Loudon (2000-2002) and Quintiles China (2002-2005); the founder of DrJ (2005 -).
Chih-Hwa Wallace Lin, PhD (SPKAGY), Director, Division of Resource Development, Center for Drug Evaluation, Taiwan
Wallace is Director for Resource Development of CDE. He was Advisor for MOEA, President of SyNovate, Associate Professor in National Chao-Tune Univ. He has worked in Carnegie-Mellon Univ. and in Medical School of Univ. of Pittsburgh after earned Ph.D. from Carnegie-Mellon Univ., in Pittsburgh, PA.
João Massud, MD (SPKNON), President, Brazilian Society of Pharmaceutical Medicine (SBMF), Brazil
Coordinator and Professor of Pharmaceutical Medicine Post-Graduation at Federal University of Sao Paulo. CEO Trials Consulting
Description
This symposium will examine innovations in drug development in China and Latin America as well as the impact of regional cooperation on global development in the Asia Pacific region.